Beranda › Dermatitis Atopik (Eksim) › New York
Uji klinis Dermatitis Atopik (Eksim) di New York
16 studi untuk Dermatitis Atopik (Eksim) mencari peserta di lokasi di New York.
Kota di New York
Teks studi resmi (Bahasa Inggris)
A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)
- OptiSkin Medical, New York
- Equity Medical, LLC, The Bronx
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 hingga 72 · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT06808477Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
- Novartis Investigative Site, Brooklyn
Menerima pesertaFase 2
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06947993Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
- Enveda Investigative Site, New York
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07298395A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
- Montefiore - Jacobi Dermatology Clinic, The Bronx
- Montefiore - Clinical Research Center, The Bronx
- Montefiore - Greene Medical Arts Pavillion, The Bronx
- dan 2 lainnya
Menerima pesertaFase 2
Usia 18 hingga 64 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07216027A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
- Investigational Site, New York
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07003425Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis
- Weill Cornell Medicine, New York
- Columbia University Irving Medical Center, New York
Menerima peserta
Usia 13 hingga 17 · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT07746427A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- Sadick Research Group, LLC, New York
Menerima pesertaFase 2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT07599813A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 6, Kew Gardens
- Inmagene Site 21, New York
- Inmagene Site 11, Woodbury
Menerima pesertaFase 2
Usia 18 hingga 74 · Semua jenis kelamin · Diperbarui 12 Agu 2026 · NCT07037901Skin Microbial Ecology in Atopic Dermatitis
- University of Rochester Medical Center, Rochester
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 13 ke atas · Semua jenis kelamin · Diperbarui 14 Jul 2026 · NCT04170244A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
- Equity Medical /ID# 265814, New York
- Weill Cornell Medicine /ID# 265793, New York
Menerima pesertaFase 3
Usia 18 hingga 63 · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT06389136Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)
- Icahn School of Medicine at Mount Sinai: Department of Pediatrics Allergy & Immunology, New York
- University of Rochester Medical Center: Department of Dermatology, Rochester
Menerima pesertaFase 1
Usia 6 ke atas · Semua jenis kelamin · Diperbarui 2 Jul 2026 · NCT06504160A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
- Empire Dermatology, East Syracuse
- Private Practice - Dr. Bobby Buka, New York
- Icahn School of Medicine at Mount Sinai, New York
- dan 1 lainnya
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Mei 2026 · NCT05995964Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
- Galderma Investigational Site - Site 7080, Auburn
- Galderma Investigational Site # 7052, East Syracuse
- Galderma Investigational Site - 8282, Mount Kisco
- dan 3 lainnya
Menerima pesertaStudi observasional
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 13 Mar 2026 · NCT06988605Allergy and Immunology Natural History Study
- Columbia University Irving Medical Center / NewYork-Presbyterian Hospital, New York
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Hingga usia 99 · Semua jenis kelamin · Diperbarui 4 Feb 2026 · NCT05584488Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome
- Icahn School of Medicine at Mount Sinai, New York
Menerima pesertaFase 2
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 2 Feb 2026 · NCT07242638A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring
- Pfizer, New York
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 0 ke atas · Wanita · Diperbarui 9 Des 2025 · NCT05721937Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.